Clinical Trials Logo

Clinical Trial Summary

This is A Multicenter, Randomized, Double-Blind, Double-Dummy, Comparative, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous Imipenem/Cilastatin/Funobactam in Comparison with Meropenem in Hospitalized Adults with Complicated Urinary Tract Infections, including Acute Pyelonephritis.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05204368
Study type Interventional
Source Evopoint Biosciences Inc.
Contact Yuanyuan Pan
Phone +86 0512-89162086
Status Not yet recruiting
Phase Phase 3
Start date March 30, 2023
Completion date December 2025

See also
  Status Clinical Trial Phase
Completed NCT04505683 - A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) Phase 2/Phase 3